News

CTI BioPharma Corp asserted that results from the Phase 3 PERSIST-2 clinical Trial of pacritinib which is an investigational JAK22 inhibitor that has been published online in JAMA…
Read More...

FDA approved the conduct of a pivotal Clinical Trial incorporating new technology to treat overactive bladder. The technology, developed and manufactured by Valencia Technologies, is…
Read More...

Amgen revealed that data from two new studies suggest barriers to access for PCSK9 inhibitors and the potential consequences of barring access for PCSK9 inhibitors and the potential…
Read More...

In order to help ensure more affordable and timely access to patients whose medical needs are unmet , Regeneron Pharmaceuticals and Sanofi will offer payers that agree to lessen…
Read More...

Royal Philips which is a global leader in health technology claimed health economic results from DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio…
Read More...

Abbott claimed new late-breaking Clinical Trial data from the MOMENTUM 3 clinical study which is the largest left ventricular assist device (LVAD) trial in the world to evaluate…
Read More...

The Janssen Pharmaceutical Companies of Johnson and Johnson announced results of new analysis exhibiting that INVOKANA remarkably lessened the risk of cardiovascular death or…
Read More...

Novartis announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the…
Read More...

Tango Therapeutics which is a biotechnology company creating novel, targeted medicines for specific cancer subtypes claimed the addition of three experienced leaders with deep…
Read More...

Eyenuk which is a leading developer of advanced artificial intelligence enabled clinically supported solutions to identify diseases via retinal image analysis declared that it has…
Read More...

TherapeuticsMD which is an innovative women's healthcare company claimed the FDA's admission of NDA for TX-001HR. TX-001HR is the company’s investigational bio-identical hormone therapy…
Read More...

InVivo Therapeutics Holdings Corporation became recipient of supplemental Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for a second…
Read More...

Tyber Medical which is a privately held company emphasizing on developing breakthrough medical devices for private label opportunities and facilitating  the science  of bioengineered…
Read More...

Ortho Clinical Diagnostics which is  a global leader of in vitro diagnostics asserted the launch of Ortho's VITROS Immunodiagnostic Products C-peptide Reagent Pack and Calibrators that…
Read More...

Wuxi Biologics and Adagene which is an emerging biotech company discovering and developing innovative antibody therapeutics for its usage globally, declared a collaboration agreement.…
Read More...

Roche declared that its new hematology testing solution, the cobas m 511 integrated hematology analyzer has received 510(k) clearance from the U.S Food and Drug Administration. The…
Read More...

Prokaryotics receives $2.5 million from the National Institute of Allergy and Infectious Diseases as a SBIR. The two-year agreement will fund research by Prokaryotics on the restoration…
Read More...

Spinal Singularity declared that the first patient has been treated with the Connected Catheter which is an innovative, smart catheter system designed for adult males with Chronic…
Read More...

Sweetch which is a mobile-health app that helps prevent and enhance outcomes in diabetes by encouraging long-term behavioral change declared thee outcomes of its clinical trial…
Read More...

According to the newly published research in Molecular and Cellular Proteomics describes a biomarker panel based on patient IgM antibodies that can certainly distinguish between Zika…
Read More...